How to tackle Misfolded Proteins in ALS
Opening Remarks:
Professor Tadao Bamba
President and Dean, Shiga University of Medical Science
Welcome Remarks
Professor Ikuo Tooyama
Director of MNRC, Shiga University of Medical Science
Introduction; gHow to direct therapeutic strategies in ALS?h
Associate Professor Makoto Urushitani
MNRC, Shiga University of Medical Science
gProtein aggregation in ALS: Cause or consequence of mutant SOD1 toxicity?h
Albrecht Clement
University of Mainz, Germany
gHigh pressure NMR reveals evolutionally conserved intermediates between ubiquitin and NEDD8h
Ryo Kitahara
Ritsumeikan University
gUnderstanding the Mechanistic Basis of TDP-43-Induced Neurotoxicity
in Amyotrophic Lateral Sclerosish
Janice Robertson
University of Toronto, Canada
gALS pathogenesis and Glial cellsh
Koji Yamanaka
RIKEN Brain Science Institute
Closing Remarks
Professor Takanori Hattori
Vice President and Dean, Shiga University of Medical Science
Professor Ikuo Tooyama
Albrecht Clement
Janice Robertson
Associate Professor Makoto Urushitani